Nasopharyngeal carcinoma
Conditions
Interventions
None listed
Sponsors
Min Huang
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Patients with newly diagnosed and confirmed non metastatic nasopharyngeal squamous cell carcinoma, who type II-III, N3 (staging, 2017, 8th Edition), received intensity modulated radiation therapy. 1. Patients aged between 18 and 70 are male and female. 2.ECOG0-1 3. Patients whose functions of important organs meet the following requirements: (1) The number of neutrophils > 1.5 * 10^9 / L, hemoglobin > 90g / L, Platelets > 90 * 10^9 / L; (2) Normal liver and kidney function: ast, ALT = 50 ml / min. 4. Women of childbearing age were required to use contraception during the study period. 5. The subjects who voluntarily joined the study signed the informed consent form with date before the specific planning steps, cooperated with regular follow-up and were able to comply with the requirements of the study.
Exclusion criteria
Exclusion criteria: 1. Patients with distant metastasis of nasopharyngeal carcinoma. 2. Subjects with PS >= 2. 3. Patients with life-threatening physical condition or other serious diseases at the same time. 4. Pregnant or lactating patients. 5. Patients with a history of other malignancies. Except for cervical carcinoma in situ, cured basal cell carcinoma, bladder surface tumor, or any cured tumor more than 3 years after study enrollment. 6. Patients who refused to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DMFS (distant metatasis-free survival); | — |
Countries
China
Contacts
Public ContactMin Huang
Jiangxi Cancer Hospital
Outcome results
None listed